Saturday, November 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Intuitive Surgical: Navigating a Crossroads of Insider Sales and Strategic Milestones

Kennethcix by Kennethcix
February 12, 2026
in Analysis, Earnings, Healthcare, Insider Trading, Tech & Software
0
Intuitive Surgical Stock
0
SHARES
55
VIEWS
Share on FacebookShare on Twitter

Intuitive Surgical finds itself at an interesting juncture, with recent insider transactions and a tempered growth outlook drawing investor scrutiny alongside a significant regulatory approval. The mixed signals present a complex picture for the robotic surgery leader.

A Closer Look at Recent Insider Transactions

Filings with the U.S. Securities and Exchange Commission this week revealed share disposals by two top executives. These sales, however, were executed under pre-arranged trading plans established under Rule 10b5-1. Such plans are standard corporate practice, allowing insiders to schedule stock sales well in advance to avoid accusations of trading on non-public information.

Specifically, Vice President and Corporate Controller Fredrik Widman disposed of 133 shares at an average price of $494.96. Separately, Chief Medical Officer Myriam Curet sold a larger block of 526 shares through a trust.

Institutional Positioning and a Revised Growth Trajectory

This insider activity coincides with notable repositioning by major institutional investors. Recent portfolio disclosures show that Caisse Des Depots et Consignations established a new position, acquiring nearly 4,000 shares. Conversely, CIBC World Markets reduced its stake by 12.7% in the latest reporting period.

These moves unfold as the company provides updated guidance. Management now forecasts global procedure growth for the current year in a range of 13% to 15%. This represents a noticeable deceleration from the approximately 18% growth achieved in the 2025 fiscal year, signaling a more moderate pace ahead.

Should investors sell immediately? Or is it worth buying Intuitive Surgical?

Strong Quarterly Performance Amidst Cautious Outlook

Despite the cautious forward look, Intuitive Surgical closed its previous fiscal year on a high note. Its fourth-quarter 2025 results surpassed market expectations:

  • Q4 2025 Revenue: $2.87 billion, an 18.8% year-over-year increase.
  • Adjusted Q4 2025 EPS: $2.53, notably above the consensus estimate of $2.27.

This operational strength, however, has not fully insulated the stock from pressure. Shares currently trade well below their 52-week high of $609.08.

The da Vinci 5 Approval: A Potential Catalyst

A key strategic development arrived on January 26, when the U.S. Food and Drug Administration granted clearance for the company’s next-generation da Vinci 5 system. The authorization includes specific cardiac surgery procedures, such as mitral valve reconstruction.

The integration and adoption rate of this new platform in the cardiac surgery segment is now a critical focus. Its commercial success is seen as a pivotal factor that could help offset the projected broader slowdown in procedure growth throughout the remainder of the year.

In summary, Intuitive Surgical presents a narrative of robust recent financial execution contrasted with insider selling and a more conservative growth forecast. The market’s attention is likely to remain split between these near-term signals and the long-term potential embodied by the newly launched da Vinci 5 system.

Ad

Intuitive Surgical Stock: Buy or Sell?! New Intuitive Surgical Analysis from November 21 delivers the answer:

The latest Intuitive Surgical figures speak for themselves: Urgent action needed for Intuitive Surgical investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 21.

Intuitive Surgical: Buy or sell? Read more here...

Tags: Intuitive Surgical
Kennethcix

Kennethcix

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
Nike Stock

A Major Investor Increases Stake in Nike Amid Strategic Overhaul

ProSiebenSat1 Media Stock

ProSiebenSat.1 Charts Digital Course Amid Advertising Downturn

Novan Stock

The Final Chapter for Novan: Shares Cease Trading as Liquidation Concludes

Recommended

WM stock news

Spire Wealth Management Shows Confidence in Churchill Downs Incorporated with New Acquisition and Bet on Future Growth

3 years ago
Chevron Stock

Chevron Shares Surge Amid Global Oil Supply Disruption

8 months ago
Q2 Holdings Stock

Inclusion in S&P SmallCap 600 Index Ignites Q2 Holdings Stock Rally

1 year ago
REV Stock

REV Group Shares Hit Record High Amid Political Scrutiny

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

Rotation, Not Panic: Retailers Test Where Tech’s Money Went

At 5.15%, the 10-Year Treasury Picks the Winners

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

Huang Exits, Cisco Reports: Who Actually Gets Paid for AI

Trending

CrowdStrike Stock
Newsletter

93% of Stocks Fall as CrowdStrike Courts Zscaler

by Stephanie Dugan
November 21, 2026
0

Dear readers, The question heading into Friday was whether Anthropic would hold its $83 offer price. It...

Nvidia Stock

Anthropic Lists at a Premium, but the Sell-Off Keeps Going

November 20, 2026
Bitcoin Stock

Anthropic’s $81 Billion IPO Meets a Market in Need of Good News

November 19, 2026
Nvidia Stock

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

November 18, 2026
Home Depot Stock

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

November 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • 93% of Stocks Fall as CrowdStrike Courts Zscaler
  • Anthropic Lists at a Premium, but the Sell-Off Keeps Going
  • Anthropic’s $81 Billion IPO Meets a Market in Need of Good News

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com